1. A method of treating an inflammatory-related disease in a human or an animal, said method comprising administering to the human or the animal a therapeutically effective amount of a compound, having a structure according to the formula:
wherein:
R1a is H;
R4a is a member selected from H, methyl, ethyl and substituted or unsubstituted aryl and substituted or unsubstituted arylalkyl;
R10a is a member selected from H, halogen, substituted or unsubstituted aryl, substituted or unsubstituted aryloxy, substituted or unsubstituted arylalkyloxy, substituted or unsubstituted arylthio, substituted or unsubstituted arylalkylthio;
R11a is a member selected from H, OH, methyl, substituted or unsubstituted aryl, substituted or unsubstituted aryloxy, substituted or unsubstituted arylalkyloxy, substituted or unsubstituted arylthio, substituted or unsubstituted arylalkylthio;
or an anhydride, solvate or pharmaceutically acceptable salt thereof.
2. The method of claim 1, further comprising administering said compound as part of a pharmaceutical formulation, said formulation further comprising a pharmaceutically acceptable excipient.
3. The method of claim 1, wherein the compound has a structure according to the formula:
4. The method of claim 3, wherein R10a is a member selected from
wherein
R15 is a member selected from CN, COOH and
R16 and R17 are members independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl;
p is an integer selected from 1 to 5;
z is an integer selected from 1 to 8; and
X is a member selected from S and O.
5. The method of claim 1, wherein the inflammatory-related disease is selected from the group consisting of arthritis, an inflammatory bowel disease, psoriasis, multiple sclerosis, a neurodegenerative disorder, congestive heart failure, stroke, aortic valve stenosis, kidney failure, lupus, pancreatitis, allergy, atherosclerosis, a metabolic disease, a bone disease, a cardiovascular disease, a chemotherapyradiation related complication, diabetes type I, diabetes type II, a liver disease, a gastrointestinal disorder, an ophthalmological disease, allergic conjunctivitis, diabetic retinopathy, Sjogren’s syndrome, uveitis, a pulmonary disorder, a renal disease, HIV-related cachexia, cerebral malaria, ankylosing spondylitis, leprosy, anemia, and fibromyalgia.
6. The method of claim 5, wherein the neurodegenerative disorder is a member selected from Alzheimer’s disease and Parkinson disease, the inflammatory bowel disease is a member selected from Crohn’s disease or ulcerative colitis; the gastrointestinal complication is diarrhea; the liver disease is a member selected from an autoimmune hepatitis, hepatitis C, primary biliary cirrhosis, primary sclerosing cholangitis and fulminant liver failure; the gastrointestinal disorder is a member selected from celiac disease and non-specific colitis; the pulmonary disorder is a member selected from allergic rhinitis, asthma, chronic obstructive pulmonary disease, chronic granulomatous inflammation, cystic fibrosis, and sarcoidosis; the cardiovascular disease is a member selected from atheroscleotic cardiac disease, congestive heart failure and restenosis; and the renal disease is a member selected from glomerulonephritis and vasculitis.
7. The method of claim 1, wherein the inflammatory-related disease is dermatitis or eczema.
8. The method of claim 1, wherein the inflammatory-related disease is contact dermatitis.
9. The method of claim 1, wherein the inflammatory-related disease is atopic dermatitis.
10. The method of claim 1, wherein the inflammatory-related disease is rheumatoid arthritis or psoriatic arthritis.
11. The method of claim 1, wherein the inflammatory-related disease is psoriasis.
12. The method of claim 1, wherein the inflammatory-related disease is rhinitis,
13. The method of claim 1, wherein the inflammatory-related disease is allergic rhinitis.
14. The method of claim 1, wherein the inflammatory-related disease is chronic obstructive pulmonary disease.
15. The method of claim 1, wherein the inflammatory-related disease is asthma.
16. The method of claim 1, wherein the inflammatory-related disease is bronchial asthma.
17. The method of claim 1, wherein the inflammatory-related disease is allergic conjunctivitis.
18. The method of claim 1, wherein the inflammatory-related disease is dry eye disease.
19. The method of claim 1, wherein the inflammatory-related disease is uveitis.
20. The method of claim , wherein the inflammatory-related disease is Behcet’s disease.
21. The method of claim 1, wherein the inflammatory-related disease is sarcoidosis.
22. The method of claim 1, wherein the inflammatory-related disease is Crohn’s disease.
23. The method of claim 1, wherein the inflammatory-related disease is ulcerative colitis.
24. The method of claim 1, wherein the inflammatory-related disease is actinic keratosis.
25. The method of claim 1, wherein the inflammatory-related disease is ankylosing spondylitis.
26. The method of claim 1, wherein said compound is present in a form which is a member selected from a hydrate with water, a solvate with an alcohol, an adduct with an amino compound, and an adduct with an acid.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. A roof device for a vehicle comprising;
a first movable panel placed on a front portion of an opening portion of a vehicle roof and movable between a normal position which covers the front portion of the opening portion of the vehicle roof and an operation position in which a rear end portion of the first movable panel is raised with a front end portion of the first movable panel as a pivoting point;
a second movable panel placed in a rear portion of the first movable panel placed on the opening portion of the vehicle roof;
an edge member placed at the rear end portion of the first movable panel and extended in a width direction of the vehicle; and
a first groove portion formed on the edge member at the rear end thereof, being extended in the width direction of the vehicle and opening in an upward direction relative to the vehicle.
2. A roof device for a vehicle according to claim 1, further comprising;
a seal member placed at a space between the first movable panel and the second movable panel;
a second groove portion formed in the seal portion, opening in the upward direction relative to the vehicle and extended in the width direction of the vehicle; and
a convex portion formed in the edge member, extended in the width direction of the vehicle and projected in the downward direction relative to the vehicle, wherein the convex portion is positioned above the second groove portion when the first movable panel is positioned in the operation position.
3. A roof device for a vehicle according to claim 2, wherein the seal member is deformable.
4. A roof device for a vehicle according to claim 1, wherein the first movable panel and the second movable panel are made of a glass material and having rectangular shapes, the first movable panel being provided with the edge member at the rear end portion thereof, and the second movable being provided with a retainer at a front end portion to hold the seal member between the retainer and the edge member.
5. A roof device for a vehicle according to claim 1, wherein the second movable panel slides along a longitudinal direction of the vehicle.
6. A roof device for a vehicle comprising;
a first movable panel placed on a front portion of an opening portion of a vehicle roof and movable between a normal position which covers the front portion of the opening portion of the vehicle roof and an operation position in which a rear end portion of the first movable panel is raised with a front end portion of the first movable panel as a pivoting point;
a second movable panel placed in a rear portion of the first movable panel placed on the opening portion of the vehicle roof;
an edge member placed at the rear end portion of the first movable panel and extended in a width direction of the vehicle;
first groove portion formed on the edge member at the rear end thereof, being extended in the width direction of the vehicle and opening in an upward direction relative to the vehicle:
a seal member placed at a space between the first movable panel and the second movable panel;
a second groove portion formed in the seal member, opening in the upward direction relative to the vehicle and extended in the width direction of the vehicle; and
a convex portion formed in the edge member, extended in the width direction of the vehicle and projected in the downward direction relative to the vehicle, wherein the convex portion is positioned above the second groove portion when the first movable panel is positioned in the operation position.
7. A roof device for a vehicle according to claim 3, wherein the first movable panel and the second movable panel are made of a glass material and having rectangular shapes, the first movable panel being provided with the edge member at the rear end portion thereof, and the second movable being provided with a retainer at a front end portion to hold the seal member between the retainer and the edge member.
8. A roof device for a vehicle according to claim 6, wherein the seal member is deformable.
9. A roof device for a vehicle according to claim 6, wherein the second movable panel slides along the longitudinal direction of the vehicle.